As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Jyong Biotech Ltd. The largest reported stake is Perfect Minds Co., Ltd's, at 33.34%. One filing is on record since April 24, 2026 (Schedule 13D, April 24, 2026).
Sell to companies like Jyong Biotech Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Jyong Biotech Ltd. has 1 Schedule 13D or 13G filing on record since 2026-04-24. 1 holder's latest filing reports 5% or more of ordinary shares, par value $0.00001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Perfect Minds Co., Ltd | 33.34% | 25,349,500 | SCHEDULE 13D, 2026-04-24 | 2025-06-16 |
Holding shares or following this stake? See who's behind Jyong Biotech Ltd. and the warning signs.
Free to see. No signup.
Keep reading
More on Jyong Biotech Ltd. and the records around it.
Jyong Biotech Ltd. elsewhere on the record
Watch Jyong Biotech Ltd.
Get an email when Jyong Biotech Ltd. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Jyong Biotech Ltd.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Jyong Biotech Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Jyong Biotech Ltd. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Perfect Minds Co., Ltd
The Reporting Persons hold the ordinary shares of the Issuer for investment purposes. Except as set forth above, the Reporting Person has no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.Item 4 of the SCHEDULE 13D filed 2026-04-24
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-04-24 | Perfect Minds Co., Ltd | 33.34% | SCHEDULE 13D |
Also on the record for Jyong Biotech Ltd.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| June 18, 2025 | IPO filing, Form 424B4 | $7.5 a share | IPO filings | Source |
| March 11, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| February 6, 2025 | IPO filing, Form F-1/A | — | IPO filings | Source |
| December 19, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| November 21, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| November 1, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| October 4, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| September 16, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
| August 2, 2024 | IPO filing, Form F-1/A | — | IPO filings | Source |
Tools for this story
Each opens in a new tab, filled in for Jyong Biotech Ltd.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.